FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 118 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $350,858 | +121.5% | 9,314 | 0.0% | 0.01% | +150.0% |
Q4 2020 | $158,431 | +97.8% | 9,314 | -29.9% | 0.00% | +100.0% |
Q2 2019 | $80,096 | -55.0% | 13,283 | 0.0% | 0.00% | -66.7% |
Q1 2019 | $177,992 | +44.1% | 13,283 | 0.0% | 0.00% | +50.0% |
Q4 2018 | $123,532 | -33.2% | 13,283 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $184,899 | -99.9% | 13,283 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $210,004,000 | +26.3% | 13,283 | +37.2% | 0.00% | +50.0% |
Q1 2018 | $166,285,000 | +83882.3% | 9,679 | +7.0% | 0.00% | -33.3% |
Q4 2017 | $198,000 | -75.0% | 9,044 | -53.2% | 0.00% | -40.0% |
Q3 2017 | $791,000 | +35.9% | 19,333 | 0.0% | 0.01% | +25.0% |
Q2 2017 | $582,000 | -16.7% | 19,333 | 0.0% | 0.00% | -20.0% |
Q1 2017 | $699,000 | -27.9% | 19,333 | 0.0% | 0.01% | -28.6% |
Q4 2016 | $969,000 | -7.1% | 19,333 | -2.7% | 0.01% | -12.5% |
Q3 2016 | $1,043,000 | +26.9% | 19,875 | 0.0% | 0.01% | +33.3% |
Q2 2016 | $822,000 | +12.6% | 19,875 | +10.6% | 0.01% | 0.0% |
Q1 2016 | $730,000 | +13.2% | 17,967 | +15.6% | 0.01% | +20.0% |
Q4 2015 | $645,000 | +176.8% | 15,537 | +2.8% | 0.01% | +150.0% |
Q3 2015 | $233,000 | -38.0% | 15,117 | 0.0% | 0.00% | -33.3% |
Q2 2015 | $376,000 | +16.8% | 15,117 | +7.2% | 0.00% | +50.0% |
Q1 2015 | $322,000 | -15.5% | 14,105 | 0.0% | 0.00% | -33.3% |
Q4 2014 | $381,000 | +130.9% | 14,105 | 0.0% | 0.00% | +200.0% |
Q3 2014 | $165,000 | -24.7% | 14,105 | 0.0% | 0.00% | -50.0% |
Q2 2014 | $219,000 | – | 14,105 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|